Management of metastatic high-risk gestational trophoblastic neoplasia figo stages II-IV: Risk factor score ≥ 7

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 55, Issue 5-6, 2010, Pages 199-207

  Lurain, John R ^a   Singh, Diljeet K ^a   Schink, Julian C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemotherapy; Choriocarcinoma; GTN

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; MESNA; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SALVAGE THERAPY; SCORING SYSTEM; TREATMENT RESPONSE; TROPHOBLASTIC TUMOR; DRUG RESISTANCE; METASTASIS; PATHOLOGY; PREGNANCY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; UTERUS CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IFOSFAMIDE; NEOPLASM STAGING; PREGNANCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 77957671306     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lurain JR: Advances in management of high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:451-459
2. Ngan S, Seckl MJ. Gestational trophoblastic neoplasia management: An update. Curr Opin Oncol 2007;19:486-491
3. Hertz R, Lewis J Jr, Lipsett MD: Five years experience with chemotherapy of metastatic choriocarcinoma and related tumors in women. Am J Obstet Gynecol 1961;82:631-640
4. Ross GT, Goldstein DP, Hertz R, et al: Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women. Am J Obstet Gynecol 1965;93:223-229
5. Miller DS, Lurain JR: Classification and staging of gestational trophoblastic tumors. Obstet Gynecol Clin North Am 1988;15:477-490
6. World Health Organization Scientific Group on Gestational Trophoblastic Diseases: Gestational Trophoblastic Diseases. WHO Tech Rep Ser 692, 1983
7. Ngan HYS, Bender H, Benedet JL, et al: Gestational trophoblastic neoplasia. FIGO staging and classification. Int J Gynecol Obstet 2003;83:175-177
8. Brewer JI, Eckman TR, Dolkart RE, et al: Gestational trophoblastic disease: A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma. Am J Obstet Gynecol 1971;109:335-340
9. Hammond CB, Borchert LG, Tyrey L, et al:Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 1973;15:451-457
10. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
11. Surwit EA, Hammond CB: Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol 1980;55:565-570
12. Jones WB, Lewis JL Jr: Treatment of gestational trophoblastic disease. Am J Obstet Gynecol 1974;120:14-20
13. Lurain JR, Brewer JI, Torok EE, et al: Gestational trophoblastic disease: Treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 1982;60:354-360
14. Hammond CB, Weed JC Jr, Currie JL: The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-856
15. Berkowitz RS, Goldstein DP, Bernstein MR: Modified triple chemotherapy in the management of high-risk gestational trophoblastic tumors. Gynecol Oncol 1984;9:173-181
16. Gordon AN, Gershenson DM, Copeland LJ, et al: High-risk metastatic gestational trophoblastic disease. Obstet Gynecol 1985;65:550-556
17. Lurain JR, Brewer JI: Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D and cyclophosphamide chemotherapy. Obstet Gynecol 1985;65: 830-834
18. Begent RHJ, Bagshawe KD: The management of high-risk choriocarcinoma. Semin Oncol 1982;9:198-203
19. Curry SL, Blessing JA, DiSaia PJ, et al: A prospective randomized comparison of methotrexate, actinomycin D and chlorambucil (MAC) versus modified Bagshawe regimen in "poor prognosis" gestational trophoblastic disease. Obstet Gynecol 1989;73:357-362
20. Newlands ES, Bagshawe KD, Begent RHJ, et al: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumors, 1979-1989. BJOG 1991;98:550-557
21. Bower M, Newlands ES, Holden L, et al: EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
22. Kim SJ, Bae SN, Kim JH, et al: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-253
23. Matsui H, Suzuka K, Iituka Y, et al: Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 2000;78:28-31
24. Lurain JR, Singh DK, Schink JC: Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 2006;51:767-772
25. Turan T, Karacay O, Tulunay G, et al: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer 2006;16:1432-1438
26. Lu WG, Ye F, Shen YM, et al: EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: A clinical analysis of 54 patients. Int J Gynecol Cancer 2008;18:357-362
27. Escobar PF, Lurain JR, Singh DK, et al: Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 2003;91:552-557
28. Lurain JR, Nejad B: Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97: 618-623
29. Newlands ES, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-859
30. Mao Y, Wan X, Lu W, Xie X: Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EPEMA) regimen. Int J Gynecol Cancer 2007;98:44-47
31. Lurain JR, Singh DK, Schink JC: The role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51:773-776
32. Small W Jr, Lurain JR, Shetty RM, et al: Gestational trophoblastic disease metastatic to the brain. Radiology 1996;200: 277-280
33. Jones WB, Cardinale C, Lewis JL Jr: Management of highrisk gestational trophoblastic disease: The Memorial Hospital experience. Int J Gynecol Cancer 1997;7:27-33
34. Hoekstra AV, Lurain JR, Rademaker AW, et al: Gestational trophoblastic neoplasia: Treatment outcomes. Obstet Gynecol 2008;112:251-258